Scandinavian Medical Solutions AS Cash Flow Reinvestment Rate
Scandinavian Medical Solutions AS cash flow reinvestment rate. Scandinavian Medical Solutions AS (SMSMED) has a Cash Flow Reinvestment Rate of 0.85x as of September 2024, reinvesting Dkr15.13 Million (capex Dkr15.13 Million ) from operating cash flow of Dkr17.86 Million. See financial flexibility index of Scandinavian Medical Solutions AS to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Scandinavian Medical Solutions AS (2020–2024)
Cash flow reinvestment rate of Scandinavian Medical Solutions AS from 2020 to 2024. Historical reinvestment intensity for Scandinavian Medical Solutions AS across 3 annual periods. Explore SMSMED operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Scandinavian Medical Solutions AS Cash Flow Reinvestment Rate by Year (2020–2024)
Scandinavian Medical Solutions AS cash flow reinvestment rate by year from 2020 to 2024. Year-by-year capital reinvestment analysis for Scandinavian Medical Solutions AS. For the full cash flow conversion analysis, see Scandinavian Medical Solutions AS cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 5.53x | Dkr18.77 Million | Dkr3.39 Million | Dkr18.47 Million | ▲ +8193.5% |
| 2021 | 0.07x | Dkr268.50K | Dkr4.02 Million | Dkr5.00 | ▼ -95.5% |
| 2020 | 1.47x | Dkr13.79 Million | Dkr9.38 Million | Dkr13.76 Million | — |